Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH SCIENTIFIC FRAUD INVESTIGATOR WALTER STEWART

Executive Summary

NIH SCIENTIFIC FRAUD INVESTIGATOR WALTER STEWART is on temporary detail to Chairman Dingell's (D-Mich.) House Oversight & Investigations Subcommittee staff. Stewart has been with the subcommittee for about eight months, joining shortly after he appeared at April subcommittee hearings. Stewart's stint with the subcommittee is open-ended. Stewart testified at the subcommittee's April hearings as an expert in the area of uncovering scientific misconduct. For nearly five years, Stewart and NIH colleague Ned Feder, MD, have been involved in researching the accuracy of scientific literature and of scientific misconduct, particularly in NIH-supported research. The two published an article in Nature Jan. 15, 1987, analyzing alleged errors and discrepancies in 18 papers by cardiology researcher John Darsee and co-authors. Stewart and Feder have also written about a study done at MIT and co-authored by Nobel prize-winner David Baltimore. Stewart and Feder are with the National Institute of Diabetes and Digestive and Kidney Diseases. In other cases, the subcommittee is looking into a study done by a former Harvard researcher on the use of a vitamin A (tretinoin) ointment for dry eye syndrome and into the use of diagnostic procedures developed by Duke University scientists.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS014994

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel